Pharmachem Traders Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 17-11-2024
- Paid Up Capital ₹ 2.50 Cr
as on 17-11-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 14.00 Cr
as on 17-11-2024
- Revenue -55.81%
(FY 2023)
- Profit -94.10%
(FY 2023)
- Ebitda -28.48%
(FY 2023)
- Net Worth -1.51%
(FY 2023)
- Total Assets -20.99%
(FY 2023)
About Pharmachem Traders
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company has closed loans amounting to ₹14.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sachin Pal, Mahamaya Paul, and Parthasarathi Ray serve as directors at the Company.
- CIN/LLPIN
U51109WB2000PTC092603
- Company No.
092603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2000
- Date of AGM
07 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharmachem Traders?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Pal  | Director | 16-Nov-2000 | Current |
| Mahamaya Paul | Director | 16-Nov-2000 | Current |
| Parthasarathi Ray | Additional Director | 26-May-2022 | Current |
Financial Performance of Pharmachem Traders.
Pharmachem Traders Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.81% decrease. The company also saw a substantial fall in profitability, with a 94.1% decrease in profit. The company's net worth dipped by a decrease of 1.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmachem Traders?
In 2023, Pharmachem Traders had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nirkon Industries Private LtdActive 28 years 9 monthsSachin Pal, Mahamaya Paul and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Feb 2019 | ₹5.00 Cr | Satisfied |
Tamilnad Mercantile Bank Ltd Creation Date: 09 Jul 2012 | ₹2.00 Cr | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 29 Aug 2001 | ₹7.00 Cr | Satisfied |
How Many Employees Work at Pharmachem Traders?
Unlock and access historical data on people associated with Pharmachem Traders, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmachem Traders, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmachem Traders's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
